{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:43:22Z","timestamp":1789717402434,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T00:00:00Z","timestamp":1477526400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mater Sci: Mater Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s10856-016-5800-8","type":"journal-article","created":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T09:06:05Z","timestamp":1477559165000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Evaluation of complications associated with off-label use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in pediatric orthopaedics"],"prefix":"10.1007","volume":"27","author":[{"given":"Norbert","family":"Stiel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim N.","family":"Hissnauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelia","family":"Babin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten W.","family":"Schlickewei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes M.","family":"Rueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Stuecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander S.","family":"Spiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,27]]},"reference":[{"issue":"6","key":"5800_CR1","first-page":"1367","volume":"87","author":"MF Termaat","year":"2005","unstructured":"Termaat MF, Den Boer FC, Bakker FC, Patka P, Haarman HJ. Bone morphogenetic proteins. Development and clinical efficacy in the treatment of fractures and bone defects. J Bone Joint Surg Am. 2005;87(6):1367\u201378.","journal-title":"J Bone Joint Surg Am"},{"key":"5800_CR2","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.3107mr1","author":"DO Wagner","year":"2010","unstructured":"Wagner DO, Sieber C, Bhushan R, Borgermann JH, Graf D, Knaus P. BMPs: from bone to body morphogenetic proteins. Sci Signal. 2010. doi: 10.1126\/scisignal.3107mr1 .","journal-title":"Sci Signal"},{"issue":"28","key":"5800_CR3","doi-asserted-by":"crossref","first-page":"20352","DOI":"10.1016\/S0021-9258(19)88709-4","volume":"267","author":"TK Sampath","year":"1992","unstructured":"Sampath TK, Maliakal JC, Hauschka PV, Jones WK, Sasak H, Tucker RF, White KH, Coughlin JE, Tucker MM, Pang RH, et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem. 1992;267(28):20352\u201362.","journal-title":"J Biol Chem"},{"issue":"6","key":"5800_CR4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2106\/00004623-200106000-00001","volume":"83-A","author":"SL Salkeld","year":"2001","unstructured":"Salkeld SL, Patron LP, Barrack RL, Cook SD. The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone. J Bone Joint Surg Am. 2001;83-A(6):803\u201316.","journal-title":"J Bone Joint Surg Am"},{"issue":"12","key":"5800_CR5","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.addr.2012.03.014","volume":"64","author":"KW Lo","year":"2012","unstructured":"Lo KW, Ulery BD, Ashe KM, Laurencin CT. Studies of bone morphogenetic protein-based surgical repair. Adv Drug Deliv Rev. 2012;64(12):1277\u201391.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"5800_CR6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ijom.2006.10.019","volume":"36","author":"J Lan","year":"2007","unstructured":"Lan J, Wang ZF, Shi B, Xia HB, Cheng XR. The influence of recombinant human BMP-2 on bone-implant osseointegration: biomechanical testing and histomorphometric analysis. Int J Oral Maxillofac Surg. 2007;36(4):345\u201349.","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"4","key":"5800_CR7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1600-0501.2011.02164.x","volume":"23","author":"T Luo","year":"2012","unstructured":"Luo T, Zhang W, Shi B, Cheng X, Zhang Y. Enhanced bone regeneration around dental implant with bone morphogenetic protein 2 gene and vascular endothelial growth factor protein delivery. Clin Oral Implants Res. 2012;23(4):467\u201373.","journal-title":"Clin Oral Implants Res"},{"key":"5800_CR8","volume-title":"On- and off-label uses of rhBMP-2 or rhBMP-7 for spinal fusion","author":"RRA Hashimoto","year":"2012","unstructured":"Hashimoto RRA, Yoder E, McMullen K, Dettori JR. On- and off-label uses of rhBMP-2 or rhBMP-7 for spinal fusion. Olympia, WA: Washington State Health Care Authority; 2012."},{"issue":"2","key":"5800_CR9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/BPO.0b013e3181d075ab","volume":"30","author":"ME Oetgen","year":"2010","unstructured":"Oetgen ME, Richards BS. Complications associated with the use of bone morphogenetic protein in pediatric patients. J Pediatr Orthop. 2010;30(2):192\u20138.","journal-title":"J Pediatr Orthop"},{"issue":"4","key":"5800_CR10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000335424","volume":"47","author":"MM Abd-El-Barr","year":"2011","unstructured":"Abd-El-Barr MM, Cox JB, Antonucci MU, Bennett J, Murad GJ, Pincus DW. Recombinant human bone morphogenetic protein-2 as an adjunct for spine fusion in a pediatric population. Pediatr Neurosurg. 2011;47(4):266\u201371.","journal-title":"Pediatr Neurosurg"},{"issue":"14","key":"5800_CR11","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jama.2012.12929","volume":"308","author":"E Dodwell","year":"2012","unstructured":"Dodwell E, Snyder B, Wright J. Off-label use of bone morphogenetic proteins in pediatric spinal arthrodesis. Jama. 2012;308(14):1429\u201332.","journal-title":"Jama"},{"issue":"2","key":"5800_CR12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00381-013-2221-6","volume":"30","author":"LV Gressot","year":"2014","unstructured":"Gressot LV, Patel AJ, Hwang SW, Fulkerson DH, Jea A. Rh-BMP-2 for L5-S1 arthrodesis in long fusions to the pelvis for neuromuscular spinal deformity in the pediatric age group: analysis of 11 patients. Childs Nerv Syst. 2014;30(2):249\u201355.","journal-title":"Childs Nerv Syst"},{"issue":"5","key":"5800_CR13","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3171\/2011.2.PEDS10487","volume":"7","author":"TE Lindley","year":"2011","unstructured":"Lindley TE, Dahdaleh NS, Menezes AH, Abode-Iyamah KO. Complications associated with recombinant human bone morphogenetic protein use in pediatric craniocervical arthrodesis. J Neurosurg Pediatr. 2011;7(5):468\u201374.","journal-title":"J Neurosurg Pediatr"},{"issue":"1","key":"5800_CR14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3171\/2014.10.PEDS14199","volume":"16","author":"C Sayama","year":"2015","unstructured":"Sayama C, Willsey M, Chintagumpala M, Brayton A, Briceno V, Ryan SL, Luerssen TG, Hwang SW, Jea A. Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine and incidence of cancer. J Neurosurg Pediatr. 2015;16(1):4\u201313.","journal-title":"J Neurosurg Pediatr"},{"issue":"16 Suppl 1","key":"5800_CR15","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/00007632-200208151-00010","volume":"27","author":"AR Poynton","year":"2002","unstructured":"Poynton AR, Lane JM. Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine. 2002;27(16 Suppl 1):S40\u201348.","journal-title":"Spine"},{"issue":"17","key":"5800_CR16","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2106\/JBJS.L.01483","volume":"95","author":"EJ Carragee","year":"2013","unstructured":"Carragee EJ, Chu G, Rohatgi R, Hurwitz EL, Weiner BK, Yoon ST, Comer G, Kopjar B. Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis. J Bone Joint Surg Am. 2013;95(17):1537\u201345.","journal-title":"J Bone Joint Surg Am"},{"issue":"3","key":"5800_CR17","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1227\/NEU.0000000000000018","volume":"73","author":"SP Lad","year":"2013","unstructured":"Lad SP, Bagley JH, Karikari IO, Babu R, Ugiliweneza B, Kong M, Isaacs RE, Bagley CA, Gottfried ON, Patil CG, Boakye M. Cancer after spinal fusion: the role of bone morphogenetic protein. Neurosurgery. 2013;73(3):440\u20139.","journal-title":"Neurosurgery"},{"issue":"3","key":"5800_CR18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/BRS.0b013e31823fcf42","volume":"37","author":"EJ Woo","year":"2012","unstructured":"Woo EJ. Does bone morphogenetic protein increase the incidence of perioperative complications in spinal fusion? A comparison of 55,862 cases of spinal fusion with and without bone morphogenetic protein. Spine. 2012;37(3):259. author reply 259","journal-title":"Spine"},{"issue":"5","key":"5800_CR19","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1227\/NEU.0b013e3181f258ba","volume":"67","author":"DK Fahim","year":"2010","unstructured":"Fahim DK, Whitehead WE, Curry DJ, Dauser RC, Luerssen TG, Jea A. Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine: safety profile and efficacy in the early postoperative period. Neurosurgery. 2010;67(5):1195\u2013204. discussion 1204","journal-title":"Neurosurgery"},{"issue":"5","key":"5800_CR20","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/01.brs.0000201424.27509.72","volume":"31","author":"LB Shields","year":"2006","unstructured":"Shields LB, Raque GH, Glassman SD, Campbell M, Vitaz T, Harpring J, Shields CB. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine. 2006;31(5):542\u20137.","journal-title":"Spine"},{"issue":"24","key":"5800_CR21","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1097\/01.brs.0000245863.52371.c2","volume":"31","author":"JD Smucker","year":"2006","unstructured":"Smucker JD, Rhee JM, Singh K, Yoon ST, Heller JG. Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine. 2006;31(24):2813\u201319.","journal-title":"Spine"},{"issue":"2","key":"5800_CR22","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/01.bsd.0000168512.61351.3a","volume":"19","author":"SM Hansen","year":"2006","unstructured":"Hansen SM, Sasso RC. Resorptive response of rhBMP2 simulating infection in an anterior lumbar interbody fusion with a femoral ring. J Spinal Disord Tech. 2006;19(2):130\u20134.","journal-title":"J Spinal Disord Tech"},{"issue":"1","key":"5800_CR23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2106\/JBJS.H.01667","volume":"92","author":"BS Richards","year":"2010","unstructured":"Richards BS, Oetgen ME, Johnston CE. The use of rhBMP-2 for the treatment of congenital pseudarthrosis of the tibia: a case series. J Bone Joint Surg Am. 2010;92(1):177\u201385.","journal-title":"J Bone Joint Surg Am"},{"issue":"10","key":"5800_CR24","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/BOT.0000000000000117","volume":"28","author":"DS Chan","year":"2014","unstructured":"Chan DS, Garland J, Infante A, Sanders RW, Sagi HC. Wound complications associated with bone morphogenetic protein-2 in orthopaedic trauma surgery. J Orthop Trauma. 2014;28(10):599\u2013604.","journal-title":"J Orthop Trauma"},{"issue":"5","key":"5800_CR25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00024720-200210000-00001","volume":"15","author":"JK Burkus","year":"2002","unstructured":"Burkus JK, Gornet MF, Dickman CA, Zdeblick TA. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech. 2002;15(5):337\u201349.","journal-title":"J Spinal Disord Tech"},{"issue":"12","key":"5800_CR26","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/00007632-199520120-00002","volume":"20","author":"JH Schimandle","year":"1995","unstructured":"Schimandle JH, Boden SD, Hutton WC. Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine. 1995;20(12):1326\u201337.","journal-title":"Spine"},{"issue":"24","key":"5800_CR27","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1097\/00007632-199512150-00008","volume":"20","author":"HS Sandhu","year":"1995","unstructured":"Sandhu HS, Kanim LE, Kabo JM, Toth JM, Zeegan EN, Liu D, Seeger LL, Dawson EG. Evaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model. Spine. 1995;20(24):2669\u201382.","journal-title":"Spine"}],"container-title":["Journal of Materials Science: Materials in Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-016-5800-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10856-016-5800-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-016-5800-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T15:13:30Z","timestamp":1657552410000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10856-016-5800-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,27]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["5800"],"URL":"https:\/\/doi.org\/10.1007\/s10856-016-5800-8","relation":{},"ISSN":["0957-4530","1573-4838"],"issn-type":[{"value":"0957-4530","type":"print"},{"value":"1573-4838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,27]]},"article-number":"184"}}